Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG-1000 vs placebo in adult uncomplicated influenza
CTR20202536Phase 2Completed
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TG-1000 in Influenza A infection, influenza B, sponsored by TaiGen Biotechnology Co., Ltd.. Started Dec 2020; status: completed.
02
Drugs
TG-1000
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20202536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202536.